Plasticin, a type III neuronal intermediate filament protein, assembles as an obligate heteropolymer: implications for axonal flexibility.
The assembly characteristics of the neuronal intermediate filament protein plasticin were studied in SW13 cells in the presence and absence of a cytoplasmic filament network. Full-length plasticin cannot polymerize into homopolymers in filament-less SW13c1.2Vim(-) cells but efficiently coassembles with vimentin in SW13c1.1Vim(-) cells. By cotransfecting plasticin and vimentin in SW13c1.1Vim(-) cells, we show that plasticin assembly requires vimentin in noncatalytic amounts. Differing effects on assembly were seen with point mutations of plasticin monomers that were analogous to the keratin mutations that cause epidermolysis bullosa simplex (EBS). In particular, plasticin monomers with point mutations analogous to those in EBS do not uniformly inhibit neurofilament (NF) network formation. A point mutation in the helix termination sequence resulted in complete filament aggregation when coexpressed with vimentin but showed limited coassembly with low- and medium-molecular-weight NF proteins (NF-L and NF-M, respectively). In transfected SW13c1.1Vim(+) cells, a point mutation in the first heptad of the alpha-helical coil region formed equal amounts of filaments, aggregates, and a mixture of filaments and aggregates. Furthermore, coexpression of this point mutation with NF-L and NF-M was associated with a shift toward increased numbers of aggregates. These results suggest that there are important structural differences in assembly properties between homologous fish and mammalian intermediate filament proteins. These structural differences may contribute to the distinctive growth characteristics of the teleost visual pathway.
Asch
W S
WS
Department of Biochemistry and Cell Biology, Health Sciences Center, State University of New York, Stony Brook, New York 11794, USA
Schechter
N
N
D019943:Amino Acid Substitution; D000818:Animals; D001369:Axons / Q000378:metabolism*; D001704:Biopolymers / Q000378:metabolism; D002384:Catalysis; D002460:Cell Line; D016110:Epidermolysis Bullosa Simplex / Q000235:genetics; D005136:Eye Proteins / Q000235:genetics / Q000378:metabolism*; D006388:Hemagglutinins / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry; D007381:Intermediate Filament Proteins / Q000235:genetics* / Q000378:metabolism*; D007382:Intermediate Filaments / Q000235:genetics / Q000378:metabolism / Q000648:ultrastructure; D016297:Mutagenesis, Site-Directed; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism* / Q000648:ultrastructure; D010641:Phenotype; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D013696:Temperature; D014162:Transfection; D014746:Vimentin / Q000235:genetics / Q000378:metabolism; D015027:Zebrafish
D001704:Biopolymers; D005136:Eye Proteins; D006388:Hemagglutinins; D007381:Intermediate Filament Proteins; D009419:Nerve Tissue Proteins; D011993:Recombinant Fusion Proteins; D014746:Vimentin; C076104:plasticin